aahi
Accelerating Health Equity Through Innovation
We develop practical, cost-effective vaccines to fight deadly diseases such as tuberculosis, malaria, and HIV. Our mission is to translate high-impact science into scalable, field-ready solutions that save lives where they’re needed most.
Tuberculosis
10.5
Cases Annually
45% of tuberculosis cases are undiagnosed or untreated.
Leishmaniasis
70
Deaths Annually
80% of people with visceral leishmaniasis lack timely treatment.
Malaria
619
Deaths as of 2021 mostly in children
40% of those at risk for malaria lack preventive measures.
HIV
39
Living with HIV
25% of people with HIV do not receive antiretroviral therapy
These diseases disproportionately affect the world’s poorest and most vulnerable populations – and remain grossly underfunded.
Capacity Building
Our Approach
We break through barriers in global health by:
- Creating dry vaccine formulations for reduced cold chain dependency
- Formulating vaccines for needle-free delivery to provide better protection against respiratory diseases
- Building manufacturing capacity worldwide to ensure sustainable program deployment
- Educating communities on the impact that vaccines will have and promote health autonomy
We don’t just develop health solutions
We create systems that make them deployable at scale.
Partner with AAHI
With a proven track record in scientific innovation and global delivery, we design vaccines and have global CDMO partners to roll out at scale, in a cost-effective way which is sustainable.
“Every $1 invested in immunization yields an estimated $44 in economic benefits.” – GAVI
Let’s Build a Healthier World—Together
Whether you’re a donor, policymaker, researcher, or partner—we invite you to join us in reshaping what health equity looks like.
Contact Us
